Case Study: AstraZeneca to sublicense its global rights to Movantik
AstraZeneca has agreed to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada and Israel, to RedHill Biopharma (RedHill). Movantik is... Read More
Evotec, GSK, J&J, Otsuka, Gates MRI & Gates Foundation launch consortium to develop new pan-TB drug
A consortium of philanthropic, non-profit and private sector organisations launched a collaboration that aims to accelerate the development of novel “pan-TB” drug... Read More
Beximco and Mylan’s licensing deal for biosimilar in Bangladesh
Posted on28 Feb 2020
TagsBeximco Pharmaceuticals, licensing deal in pharma, Mylan, mylan licensing deal, Ogivri, trastuzumab
Comments0
Under the terms of the agreement, Beximco Pharma will receive the exclusive rights to launch Mylan’s portfolio of key monoclonal antibodies to... Read More
Insight on Hikma and Glenmark’s Exclusive Licensing Agreement for Commercialising Ryaltris Nasal Spray in the US
Posted on28 Feb 2020
Tagsdrug licensing, Glemark outlicensing, Glenmark, global pharma licensing deal, Hikma, inlicensing in pharma, Ryaltris
Comments0
Hikma Pharmaceuticals PLC and Glenmark Specialty S.A., a Swiss subsidiary of Glenmark Pharmaceuticals, a global innovative pharmaceutical company signed of an exclusive... Read More
Stada acquired 15 OTC brands of GSK
Stada Arzneimittel AG has acquired 15 consumer healthcare products, including those specializing in vitamins, cold treatments, and sore throat medication, from GlaxoSmithKline... Read More
Case Study : Rx-to-OTC switch of Voltaren arthritis pain
In this article we will be understanding about the Rx-to-OTC switch of Voltaren arthritis pain. It is one of the drug which... Read More
Analysis of Business Deal: Collegium Pharma acquired of U.S. Rights to Nucynta Franchise for $375M
Collegium Pharmaceutical, a specialty pharmaceutical company, has entered into a definitive agreement to acquire the U.S. rights to the Nucynta Franchise from... Read More
Cipla to acquire four women’s health brands from Wanbury
Cipla has acquired four brands, namely CPink, CDense, Productiv and Folinine, to further strengthen its presence in women’s health portfolio. These brands,... Read More
Insight on Curis, Aurigene collaboration for development and commercialization of CA-170
Curis, a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, announced that it has entered into... Read More
Nestlé, Valbiotis partners to develop & commercialize plant-derived active substance, TOTUM-63 to reduce risk of developing type 2 diabetes
Posted on09 Feb 2020
Comments0
Nestlé Health Science and Valbiotis, a research and development company committed to scientific innovation for preventing and combating metabolic diseases, have entered... Read More